Anti-IL17 antibody Secukinumab therapy is associated with ossification in giant cell tumor of bone: a case report of pathologic similarities and therapeutic potential similar to Denosumab

Giant cell tumor of bone is a benign, locally aggressive neoplasm. Surgical resection is the preferred treatment method. However, for cases in which resection poses an increased risk to the patient, denosumab ...

Source: BMC Musculoskeletal Disorders - April 1, 2021 Category: Orthopaedics Authors: Andrew Chandler, Meredith K. Bartelstein, Tomohiro Fujiwara, Cristina R. Antonescu, John H. Healey and Max Vaynrub Tags: Case report Source Type: research